Have a personal or library account? Click to login
Hepatitis B infection among hemodialysis patients in Al-Jazirah State: a seroepidemiological survey Cover

Hepatitis B infection among hemodialysis patients in Al-Jazirah State: a seroepidemiological survey

Open Access
|May 2023

References

  1. Liang TJ, Hepatitis B. the virus and disease. Hepatology. 2009;49 (5 Suppl):13-21.
  2. El Beltagy KE, Al. Balawi IA, Almuneef M, Memish ZA. Prevalence of hepatitis B virus markers among blood donors in a tertiary hospital in Tabuk, northwestern Saudi Arabia. Int J Infect Dis. 2008; 12(5):495-9.
  3. Alashek WA, McIntyre CW, Taal MW. Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors. BMC Infectious Dis. 2012; 12(1):265.
  4. Franco E, Bagnato B, Mariano MG, Meleleo C, Serino L, Zaratti L. Hepatitis B: Epidemiology and prevention in developing countries. World J Hepatol. 2012;4(3):74-80.
  5. Alavian SM, Bagheri-Lankarani KB, Mahdavi-Mazdeh M, Nourozi S. Hepatitis B and C in dialysis units in Iran: changing the epidemiology. Hemodial Int. 2008;12(3):378-82.
  6. Himmelfarb J, Ikizler TA. Hemodialysis. NEJM. 2010;363(19): 1833-45.
  7. Goodkin DA, Young EW, Kurokawa K, Prutz K-G, Lewin NW. Mortality among hemodialysis patients in europe, japan, and the united states: case-mix effects. Am J Kidney Dis. 2004;44(5):16-21.
  8. Batieha A, Abdallah S, Maghaireh M, Awad Z, Al-Akash N, Batieneh A, et al. Epidemiology and cost of haemodialysis in Jordan. East Mediterr Health J. 2007;13(3):654-63.
  9. Bosevska G, Kuzmanovska G, Sikole A, Dzekova-Vidimilski P, Polenakovic M. Screening for hepatitis b, c and hiv infection among patients on haemodialysis. Prilozl. 2009;30(2):159-74.
  10. Edey M, Barraclough K, Johnson DW. Review article: Hepatitis B and dialysis. Nephrology (Carlton). 2010;15(2):137-45.
  11. Wong PN, Fung TT, Mak SK, Lo KY, Tong GM, Wong Y, et al. Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol. 2005;20(11):1641-51.
  12. Amen RM. Prevalence of HBV among hemodialysis patients in Mosul city, Iraq. Tikrit J Pure Sci. 2013;18(3):10-5.
  13. Mudawi HMY. Epidemiology of viral hepatitis in Sudan. Clin Experimental Gastroenterol. 2008;1:9-13.
  14. El-kader YE-OA, Elmanama AA, Ayesh BM. Prevalence and risk factors of hepatitis B and C viruses among haemodialysis patients in Gaza strip, Palestine. Virol J. 2010;7:210.
  15. Wang C, Sun J, Zhu B, Larsen S, Yu R, Wu J, et al. Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysis. Ren Fail. 2010;32(10):1255-64.
  16. Duong TH, Nguyen PH, Henley K, Peters M. Risk factors for hepatitis B infection in rural Vietnam. Asian Pac J Cancer Prev. 2009;10(1):97-102.
  17. Abu El Makarem MA, Hamid MA, Aleem AA, Ali A, Shatat M, Sayed D, et al. Prevalence of occult hepatitis B virus infection in hemodialysis patients from egypt with or without hepatitis C virus infection. Hepat Mon. 2012;12(4):253-8.
  18. Mina, P, Georgiadou SP, Rizos C, Dalekos GN, Rigopolou EI. Prevalence of occult hepatitis B virus infection in haemodialysis patients from central Greece. WJG. 2010;16(2):225-31.
  19. Yakaryilmaz F, Gurbuz OA, Guliter S, Mert A, Songur Y, Karakan T, et al. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients. Ren Fail. 2006;28(8):729-35.
  20. El-Amin HH, Osman EM, Mekki MO, Abdelraheem MB, Ismail MO, Yousif MEA, et al. Hepatitis C virus infection in hemodialysis patients in Sudan: two centers’ report. Saudi J Kidney Dis Transpl. 2007;18(1):101-6.
  21. Gasim GI, Bella A, Adam I. Immune response to hepatitis B vaccine among patients on hemodialysis. World J Hepatol. 2015;7(2):270-5.
  22. Deisenhammer S, Radon K, Nowak D, Reichert J. Needlestick injuries during medical training. JHI. 2006;63(3):263-7.
  23. Mudawi H, Smith HM, Rahoud SA, Fletcher IA, Saeed OK, Fedail SS. Prevalence of hepatitis B virus infection in the Gezira State of Central Sudan. Saudi J Gastroenterol. 2007;13(2):81-3.
  24. Mudawi HM. Epidemiology of viral hepatitis in Sudan. Clin Exp Gastroenterol. 2008;1:9-13.
  25. Grzegorzewska AE, Hepatitis B vaccination in chronic Kidney disease: Review of evidence in non-dialyzed patients. Hepatitis Monthly. 2012;12(11):e7359.
  26. Rani M, Yang B, Nesbit R. Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organization. 2009;87:707-13.
  27. Alavian SM, Fallahian F, Lankarani KB. Implementing strategies for hepatitis B vaccination. Saudi J Kidney Dis Transpl. 2010;21(1):10.
  28. Jung M-C, Pape GR. Immunology of hepatitis B infection. The Lancet Infect Dis. 2002;2(1):43-50.
DOI: https://doi.org/10.2478/cipms-2023-0003 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 8 - 11
Submitted on: Jan 6, 2022
|
Accepted on: Oct 11, 2022
|
Published on: May 1, 2023
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2023 Ehssan H. O. Moglad, Hajir E. E. Mohammed, Hatim T.O. Ali, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.